NFKB1 and Alzheimer disease: For example, α-mangostin was clarified to treat AD disease through anti-cholinesterase, anti-amyloid-cascade, anti-inflammation and anti-oxidative activities [47], and improved memory impairment by blocking the TAK1/NF-κB signaling pathway [49].